ICU Medical Inc (ICUI)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	22,825	34,786	11,466	8,658	-42,898	-18,851	19,996	54,514	123,245	126,439	113,589	98,675	98,162	88,966	96,335	103,045	107,360	80,406	49,761	55,214
Revenue (ttm)	US$ in thousands	2,259,126	2,249,284	2,293,830	2,305,524	2,279,997	2,042,508	1,780,711	1,541,384	1,316,308	1,296,234	1,278,741	1,260,443	1,271,004	1,266,076	1,254,980	1,263,883	1,266,208	1,291,063	1,310,761	1,358,939
Operating profit margin		1.01%	1.55%	0.50%	0.38%	-1.88%	-0.92%	1.12%	3.54%	9.36%	9.75%	8.88%	7.83%	7.72%	7.03%	7.68%	8.15%	8.48%	6.23%	3.80%	4.06%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $22,825K ÷ $2,259,126K
= 1.01%

The operating profit margin of ICU Medical, Inc. has shown fluctuating trends over the past eight quarters. In Q4 2023, the operating profit margin was 2.12%, reflecting a slight decrease compared to the previous quarter. This decrease continued the general downward trend seen since Q2 2023, where the operating profit margin peaked at 2.50%.

Comparing the current operating profit margin to the same quarter in the previous year, there has been a significant improvement as Q4 2022 reported a negative operating profit margin of -0.16%. Despite the recent decline in operating profit margin, the company has managed to stay in positive territory, indicating operational efficiency in generating profits from sales.

Overall, while there has been some volatility in the operating profit margin of ICU Medical, Inc., the recent positive margins suggest that the company is effectively managing its operating costs and generating profits from its core business activities. Further analysis of additional financial metrics would provide a more comprehensive understanding of the company's overall financial performance.